FDA Approves Risankizumab for Children With Psoriasis, PsA

Published Date: 30 Jun 2026

The interleukin 23 inhibitor was approved for treating moderate-to-severe plaque psoriasis in adults in 2019 and for active psoriatic arthritis in adults in 2022.

Read Full News

Latest News

New Minoxidil Formulation Improves Hair Growth in Women

An extended-release formulation of minoxidil improves hair growth at 6 months in a small phase 2 study of women with female-pattern hair loss, the manufacturer announces.

Health Rounds: Experimental GLP-1 Drug Improves Fatty Livers Independent Of Weight Loss in Mid-stage Trial

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays)

Compression Wraps Do Not Speed Healing of Venous Leg Ulcers

Compression wraps showed slower healing times for venous leg ulcers compared with evidence-based compression strategies in a UK trial.

Hair Loss With GLP-1 Drugs Is Rare, but Real, Studies Find

The risk of hair loss in patients taking GLP-1 drugs for obesity or diabetes, while low, is higher than with other diabetes drugs, ⁠new studies suggest.

Anifrolumab Shows Promise in Refractory Dermatomyositis

Anifrolumab rapidly improves skin disease in refractory dermatomyositis and supports steroid tapering, a study shows.

US Tests GMO Flies in Rush to Fight Flesh-eating Livestock Pest

At a U.S.-funded facility in Panama, scientists are preparing to launch the first outdoor tests of genetically modified screwworm flies, a milestone in efforts to develop a...

Todays Updates

Palliative Care Remains Uncommon in Young Adults With Cancer

Concurrent palliative care use among young adults with advanced cancer is less than 20%, with substantial variation across cancer types.

Todays Updates

Palliative Care Remains Uncommon in Young Adults With Cancer

Concurrent palliative care use among young adults with advanced cancer is less than 20%, with substantial variation across cancer types.

Latest News

An extended-release formulation of minoxidil improves hair growth at 6 months in a small phase 2 study of women with female-pattern hair loss, the manufacturer announces.

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays)

Compression wraps showed slower healing times for venous leg ulcers compared with evidence-based compression strategies in a UK trial.

The risk of hair loss in patients taking GLP-1 drugs for obesity or diabetes, while low, is higher than with other diabetes drugs, ⁠new studies suggest.

Anifrolumab rapidly improves skin disease in refractory dermatomyositis and supports steroid tapering, a study shows.

At a U.S.-funded facility in Panama, scientists are preparing to launch the first outdoor tests of genetically modified screwworm flies, a milestone in efforts to develop a...

News All Time

Sunscreen Misinformation on TikTok Uncommon, but Engaging

Sunscreen use is heavily promoted on TikTok, but the relatively uncommon posts containing misinformation attract high audience engagement.

MHRA Warns of Botulism Risk After Botulinum Toxin Use

Product information now highlights the risk of toxin spread beyond the injection site, which can cause potentially fatal botulism.

Weight Loss May Lower PsA Risk in People With Psoriasis

Weight loss after a psoriasis diagnosis lowers the risk of developing psoriatic arthritis and keeping weight off matters, but there is unclear evidence on the role of weight-loss drugs.

Nonablative Fractional Laser May Remodel Skin’s Epigenome

Treatment with a 1940-nm nonablative fractional laser may modulate biological pathways linked to both skin aging and skin cancer, a new split-face study suggests.

Vitamin D Improves Cancer Treatment-Related Skin Toxicity

High-dose oral vitamin D is linked to rapid improvement in chemotherapy- and radiation-related toxic effects of the skin.

Black Patients With Cancer Gain Most From Symptom Tracking

Researchers conduct an analysis of a trial to see whether the effects of electronic symptom monitoring varied by race, age, sex, and educational attainment.

SMC Accepts First Drug to Improve Survival in Uveal Melanoma

Scotland approves tebentafusp for metastatic uveal melanoma, a rare eye cancer with a median survival of around 12 months.

Returned Travelers: Could More Than Souvenirs Come Home?

Fever, diarrhea, rash, or jaundice after international travel may indicate an imported infection. Early evaluation and detailed travel history can prevent missed diagnoses.

Can Children Stop Psoriasis Treatment After Remission?

Treatment discontinuation appears to be feasible in children with moderate-to-severe psoriasis for at least 6 months after treatment discontinuation during remission, a study finds.

Panel Provides Consensus for Standardizing CSCC Imaging

Guidelines are now available to optimize imaging for the evaluation and surveillance of cutaneous squamous cell carcinoma, a document that is expected to inform future guidelines.

FPT Plus Pulsed Dye Laser Effective for Port-Wine Birthmarks

Sequential 1550-nm fractional focal point technology followed by pulsed dye laser is safe and effective for reducing resistant port-wine birthmarks, a new study suggests.

Unapproved Peptides Common in Australia Despite Crackdown

Online sales of unapproved peptides are booming, and patients injecting these drugs are increasingly presenting to EDs with severe or life-threatening side effects.

Skin Cancer: 5 Practical Tips for Earlier Detection

Five practical strategies can help clinicians recognize suspicious skin lesions early and support timely biopsy, referral, and diagnosis of skin cancer.

Dermatology AI Is Here. Now Comes the Hard Part

A new UK initiative aims to ensure AI is used safely and effectively, as early NHS experience shows both the promise and limits of AI-enabled skin cancer screening.

Candida auris Infections Persist, CDC Report Shows

Clinical and screening cases of C auris doubled between 2022 and 2024.

Tumor Biomarker Improves Surveillance of MCC Recurrences

Circulating tumor DNA detects Merkel cell carcinoma recurrence more accurately than Merkel cell polyomavirus antibodies, study finds.

Recommended News For You

A hint regarding aspirin, the connection to colon cancer, the approval of the new Lutathera, artificial intelligence, and electronic records.

Housing aid linked to lower medical financial hardship among US renters with cancer

The Early Progression of Prostate Cancer Is Not Stopped by Metformin.

Breast Cancer Patients Living Longer Post-Medicaid Expansion

Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients

A small rise in cancer was observed following the 1986 Chernobyl accident.

Number of cancer survivors in the US reaches 18.6 million—projected to exceed 22 million by 2035

Recommended Articles For You

Exploring New Solutions for MCV Low: Unlocking the Potential for Improved Health 

Multi-Omic Rejuvenation of Aged Tissues With Transient Reprogramming and Its Therapeutic Potential 

Unlocking the Secret to Accurate ANC Calculation with This Informative Blog Post 

A New Hope: Exploring the Potential of Pegaspargase in Treating Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

More men with prostate cancer are avoiding unnecessary surgery

2.

Even when they are not paying attention, children are still learning.

3.

FDA Approves New Bladder Cancer First-Line Standard of Care.

4.

"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.

5.

AI is useful in low-resource areas for triaging breast masses.

1.

Community Cancer Awareness Through Survivor Advocacy Networks

2.

Evidence-Based Pathways for Survivorship Care Planning

3.

Red Blood Cell Aging and Clinical Implications

4.

Understanding Phyllodes Tumor: Symptoms, Diagnosis, and Treatment Options

5.

Clinical Trends in Oncology in Clinical Decision-Making

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Navigating the Complexities of Ph Negative ALL - Part VI

2.

Efficient Management of First line ALK-rearranged NSCLC - Part V

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

4.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion

5.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot